 BEDMER, N.J., May 05, 2022 GLOBE NEWSWIRE -- Matinas BioPharma Holdings, Inc. NYSE AMER: MTNB, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal LNC platform technology, today announced the Company will host a conference call and live audio webcast on Thursday, May 12, 2022 at 8:30 a.m. ET to discuss operational and financial results for the first quarter ended March 31, 2022. 